A Phase 1 Evaluation of the Safety and Immunogenicity of a Booster Dose of TV003 Administered 12 Months After Initial Vaccination With TV003
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Dengue vaccine (Primary)
- Indications Dengue
- Focus Adverse reactions; Pharmacodynamics
- 14 Jun 2017 Biomarkers information updated
- 11 Feb 2013 New trial record